Indian Pharmaceutical Alliance (IP Alliance) has organised the 9th Advanced Good Manufacturing Practices (GMP) Workshop, a two-day workshop held virtually featuring over 25 distinguished industry leaders, subject matter experts, and global regulators, including US FDA and CDSCO. The workshop featured sessions covering pertinent topics and future trends, including strategies for addressing inspection outcomes, operational excellence, quality assurance in BA/BE studies, driving regulatory harmonization, enhancing data governance and sustainability. Dr Rajeev Raghuvanshi, Drugs Controller General of India, CDSCO, Government of India, said, "At the heart of the pharmaceutical industry lies one unwavering principle: Quality. It’s not just a goal; it is the foundation of our global leadership, and the trust placed in us." "The world is increasingly looking towards India, not just for our contributions to generic medicines, but for our growing leadership in advanced areas like biologics, medical devices, and digital health,” he added. Nilesh Gupta, chair, quality forum, IP Alliance & managing director, Lupin, said, “Our industry’s reputation, and more importantly, the trust of millions of patients worldwide, are built on the cornerstone of quality. It is encouraging to see that the Indian pharmaceutical sector is making significant strides towards becoming a global benchmark for quality through capability building, process improvements, talent development, digitalization, and fostering a quality-first mindset.” Sudarshan Jain, secretary general, IP Alliance, said, "The 9th Advanced GMP Workshop has provided a platform for collaboration, equipping industry leaders and regulators with the tools and insights necessary to meet the highest international standards". IP Alliance leadership is committed to strengthening operational capabilities and ensuring that patients worldwide have access to affordable and quality assured medicines, he added. The workshop was attended by over 2,500 professionals including CXOs of pharma industry, academia, and leaders from WHO, US FDA, CDSCO, IGBA, PDA, USP, and other industry associations. IP Alliance also announced the dates of the flagship pharma event of the year - the 10th Global Pharmaceutical Quality Summit, which will be organized on 27 & 28 February 2025 in Mumbai.
|